Skip to main content
. 2013 Nov 15;48(2):130–136. doi: 10.1007/s13139-013-0248-y

Table 2.

Results for SUVmax, SUVmean, and serum SCC level pre- and post-treatment

Patients with
complete response (n = 124)
Patients with
residual tumor (n = 12)
Pre-treatment SUVmax 12.7 ± 6.1 18.4 ± 1.1 NS
SUVmean 7.2 ± 4.2 12.8 ± 6.9 p < 0.001
SCC (ng/ml) 14.2 ± 2.9 30.0 ± 6.8 NS
Post-treatment SUVmax 2.5 ± 0.8 5.7 ± 2.6 p < 0.001
SUVmean 1.9 ± 0.7 3.7 ± 1.7 p < 0.001
SCC (ng/ml) 1.6 ± 2.2 3.6 ± 4.2 NS